A new “magic mushroom” drug could treat depression without psychedelic hallucinations

Scientists are exploring a new way to harness the medical promise of psychedelic compounds without the mind-bending side effects. Researchers created modified versions of psilocin — the active form of psilocybin from “magic mushrooms” — that still target key serotonin pathways linked to depression and other brain disorders but appear to cause far fewer psychedelic-like effects.
MoMath Brings Prime Numbers to a Prime New Location
After outgrowing its original home, the National Museum of Mathematics has added new exhib…









